NEC and Taiho selected for NEDO quantum immunotherapy demo program
NEC and Taiho Pharmaceutical are involved in a joint R&D project using quantum computing for next-generation cancer immunotherapy, selected for a NEDO demonstration program.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.